Previous studies have shown that AI can be used to detect liver fibrosis and diagnose non-alcoholic fatty liver disease (NAFLD). It can also help differentiate focal liver lesions, diagnose ...

Ipsen presents 3 late-breaking presentations and 8 abstracts across rare cholestatic liver disease portfolio at AASLD 2024PARIS, FRANCE, 18 ...

Since the adoption of a new model for assessing the severity of liver disease, women are more likely to be added to the waitlist for a liver ...

Whakatāne man Rhys Drayson was diagnosed with liver cancer in 2022 after he developed hepatitis C from a blood transfusion in ...

Thanks to the living donor program at Children's Hospital Colorado, a Texas girl found a match for a new liver.

TransMedics Group (NASDAQ: TMDX) has emerged as a medical devices industry leader, capturing strong growth and climbing ...

It was all smiles and hugs Thursday at IU Health University Hospital when Morten Pedersen and his wife Beth walked through ...

The sNDA was submitted to support full approval of OCA for this indication based on data from the COBALT trial, as well as real-world evidence.

In the wake of an unfavorable advisory committee meeting in September, Intercept Pharmaceuticals’ bid to win full approval ...

TransMedics' Q3 results were weak, but long-term growth opportunities remain. Learn why TMDX stock is a compelling buy ...

The FDA informed Intercept that it is unable to approve the sNDA in its current form, consistent with the outcome of the Gastrointestinal Drugs Advisory Committee (GIDAC) meeting in September 2024. In ...